Change in Ratings
downgraded at JPMorgan to Neutral from Overweight following announcement that financial restatement will again be delayed. See limited near-term upside as uncertainty continues.
Johnson & Johnson
downgraded at UBS to Neutral from Buy. Fiscal 2009 EPS estimates lowered to $4.69 from $4.70. Price target raised to $77 from $73.
downgraded at Merrill to Neutral. $31 price target. Competition will likely continue to erode margins over the coming quarters.
coverage reinstated at Goldman with a Buy rating, as M&A talks with
have subsided. Price target at $48.
Stock Comments/EPS Changes
Melco Crown Entertainment
numbers lowered at Jefferies. 2008 EPS estimates lowered to $0.16 from $0.22. Price target lowered to $18 from $19. Maintains Buy rating.
numbers raised at Jefferies. Fiscal 2009 EPS estimates raised to $3.53 from $3.50. Price target raised to $70 from $69. Maintains Buy rating.
This article was written by a staff member of TheStreet.com.